$CDZI
CADIZ INC Stock $cdzi

$cdzi Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000143774922012159 Filed on May 12, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$142.0K	$139.0K
YoY Change	2.16%	21.93%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.806M	$3.230M
YoY Change	17.83%	-18.84%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$121.0K	$103.0K
YoY Change	17.48%	30.38%
% of Gross Profit
Operating Expenses	$3.927M	$3.340M
YoY Change	17.57%	-17.73%
Operating Profit	-$3.785M	-$3.197M
YoY Change	18.39%	-18.9%
Interest Expense	$1.991M	$2.542M
YoY Change	-21.68%	-28.84%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$5.776M	-$5.739M
YoY Change	0.64%	-71.14%
Income Tax	$2.000K	$2.000K
% Of Pretax Income
Net Earnings	-$5.912M	-$5.944M
YoY Change	-0.54%	-71.02%
Net Earnings / Revenue	-4163.38%	-4276.26%
Basic Earnings Per Share	-$0.16	-$0.16
Diluted Earnings Per Share	-$133.1K	-$157.0K
COMMON SHARES
Basic Shares Outstanding	44.43M	37.83M
Diluted Shares Outstanding		37.83K

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.82M	$18.70M
YoY Change	0.64%	78.1%
Cash & Equivalents	$18.82M	$18.67M
Short-Term Investments
Other Short-Term Assets	$2.058M	$800.0K
YoY Change	157.25%	33.33%
Inventory
Prepaid Expenses
Receivables	$124.0K	$18.00K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$21.00M	$19.51M
YoY Change	7.66%	73.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$79.38M	$53.70M
YoY Change	47.81%	4.03%
Goodwill	$3.813M	$3.813M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$942.0K	$1.288M
YoY Change	-26.86%	25.29%
Other Assets	$4.567M	$4.936M
YoY Change	-7.48%	12.75%
Total Long-Term Assets	$98.74M	$70.04M
YoY Change	40.97%	11.45%
TOTAL ASSETS
Total Short-Term Assets	$21.00M	$19.51M
Total Long-Term Assets	$98.74M	$70.04M
Total Assets	$119.7M	$89.55M
YoY Change	33.71%	20.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.095M	$177.0K
YoY Change	518.64%	-81.58%
Accrued Expenses	$1.539M	$2.066M
YoY Change	-25.51%	111.9%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$82.00K	$47.00K
YoY Change	74.47%	135.0%
Total Short-Term Liabilities	$4.006M	$2.316M
YoY Change	72.97%	-49.08%
LONG-TERM LIABILITIES
Long-Term Debt	$47.03M	$78.92M
YoY Change	-40.41%	9.01%
Other Long-Term Liabilities	$33.00K	$21.40M
YoY Change	-99.85%	713233.33%
Total Long-Term Liabilities	$47.06M	$78.92M
YoY Change	-40.37%	9.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.006M	$2.316M
Total Long-Term Liabilities	$47.06M	$78.92M
Total Liabilities	$74.13M	$102.6M
YoY Change	-27.75%	9.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$580.6M	-$545.4M
YoY Change	6.46%	4.45%
Common Stock	$506.0K	$382.0K
YoY Change	32.46%	10.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$45.61M	-$13.05M
YoY Change
Total Liabilities & Shareholders Equity	$119.7M	$89.55M
YoY Change	33.71%	20.9%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$5.912M	-$5.944M
YoY Change	-0.54%	-71.02%
Depreciation, Depletion And Amortization	$121.0K	$103.0K
YoY Change	17.48%	30.38%
Cash From Operating Activities	-$3.200M	-$2.823M
YoY Change	13.35%	-35.53%
INVESTING ACTIVITIES
Capital Expenditures	$530.0K	$513.0K
YoY Change	3.31%	-85.14%
Acquisitions
YoY Change
Other Investing Activities	-$100.0K	-$140.0K
YoY Change	-28.57%	-88.71%
Cash From Investing Activities	-$630.0K	-$650.0K
YoY Change	-3.08%	-86.15%
FINANCING ACTIVITIES
Cash Dividend Paid	$1.288M	$0.00
YoY Change
Common Stock Issuance & Retirement, Net	$11.74M	$14.87M
YoY Change	-21.03%	278.97%
Debt Paid & Issued, Net	$35.00K	$13.00K
YoY Change	169.23%	-13.33%
Cash From Financing Activities	$10.42M	$14.85M
YoY Change	-29.86%	280.09%
NET CHANGE
Cash From Operating Activities	-$3.200M	-$2.823M
Cash From Investing Activities	-$630.0K	-$650.0K
Cash From Financing Activities	$10.42M	$14.85M
Net Change In Cash	$6.566M	$11.38M
YoY Change	-42.31%	-320.39%
FREE CASH FLOW
Cash From Operating Activities	-$3.200M	-$2.823M
Capital Expenditures	$530.0K	$513.0K
Free Cash Flow	-$3.730M	-$3.336M
YoY Change	11.81%	-57.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50770275
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	329
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	329
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	103000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	3927000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	3336000	USD
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50750304
CY2013Q1	cdzi	Number Of Milestones For Common Stock Issuance NumberOfMilestonesForCommonStockIssuance	2	pure
CY2013Q1	cdzi	Shares Payable Term From Date Earned SharesPayableTermFromDateEarned	P3Y
CY2022Q1	us-gaap	Revenues Revenues	142000	USD
CY2021Q1	us-gaap	Revenues Revenues	139000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3806000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3233000	USD
CY2022Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	121000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	329
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	329
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50750304
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50750304
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43656169
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43656169
CY2022Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.08875	pure
CY2022Q1	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	550
CY2022Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3785000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3197000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	1991000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	2542000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-5776000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-5739000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-134000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-203000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5912000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5944000	USD
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1265000	USD
CY2021Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7177000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5944000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44433000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37834000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18819000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10965000	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1265000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1288000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	124000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	270000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	793000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	691000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	21001000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	82000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	107000	USD
CY2022Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	1265000	USD
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1288000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	13214000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79381000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	78890000	USD
CY2022Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	420000	USD
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	420000	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	942000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	976000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	3813000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	3813000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3275000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3281000	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6338000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	7603000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4567000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4296000	USD
CY2022Q1	us-gaap	Assets Assets	119737000	USD
CY2021Q4	us-gaap	Assets Assets	112493000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1095000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	286000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1539000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	808000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	24000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4006000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2513000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	47029000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	46477000	USD
CY2022Q1	cdzi	Lessor Operating Lease Deposit Liabilities LessorOperatingLeaseDepositLiabilities	19303000	USD
CY2021Q4	cdzi	Lessor Operating Lease Deposit Liabilities LessorOperatingLeaseDepositLiabilities	18855000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3010000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3257000	USD
CY2022Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	750000	USD
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	750000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	33000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	74131000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	71884000	USD
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	1000	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	506000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	436000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	625675000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	613572000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-580577000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-573400000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	45606000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	40609000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	119737000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112493000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5912000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5944000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	121000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	103000	USD
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	568000	USD
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	453000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	15000	USD
CY2022Q1	cdzi	Paid In Kind Interest Added To Loan Principal PaidInKindInterestAddedToLoanPrincipal	0	USD
CY2021Q1	cdzi	Paid In Kind Interest Added To Loan Principal PaidInKindInterestAddedToLoanPrincipal	1792000	USD
CY2022Q1	cdzi	Paid In Kind Interest Added To Lease Liability PaidInKindInterestAddedToLeaseLiability	442000	USD
CY2021Q1	cdzi	Paid In Kind Interest Added To Lease Liability PaidInKindInterestAddedToLeaseLiability	390000	USD
CY2022Q1	cdzi	Income Loss From Equity Method Investments Excluding Investing Activities IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities	-134000	USD
CY2021Q1	cdzi	Income Loss From Equity Method Investments Excluding Investing Activities IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities	-203000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	433000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	147000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-573000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-146000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-37000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	102000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	127000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	271000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	272000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	664000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-188000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-246000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-255000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	795000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1396000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3222000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2823000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	530000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	513000	USD
CY2022Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	100000	USD
CY2021Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	137000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-630000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-650000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11741000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	14867000	USD
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1288000	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	-0	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	35000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	13000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10418000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14854000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6566000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11381000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19856000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7424000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26422000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18805000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	40609000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	433000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11741000	USD
CY2022Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1265000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5912000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	45606000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-25301000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	148000	USD
CY2021Q1	cdzi	Adjustments To Additional Paid In Capital Reclassification Of Warrant Liability AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantLiability	3179000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5944000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-13052000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5900000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5900000	USD
CY2022Q1	cdzi	Working Capital WorkingCapital	17000000.0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3200000	USD
CY2021Q3	cdzi	Deposits Segregated Account Prefund Eight Quarterly Dividend Payments DepositsSegregatedAccountPrefundEightQuarterlyDividendPayments	10200000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	875000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18819000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10965000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18671000	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1265000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1288000	USD
CY2021Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6338000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	7603000	USD
CY2021Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	134000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26422000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19856000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18805000	USD
CY2021Q3	cdzi	Deposits Segregated Account Prefund Eight Quarterly Dividend Payments DepositsSegregatedAccountPrefundEightQuarterlyDividendPayments	10200000	USD
CY2021Q2	cdzi	Water Supply Agreement Number Of Acrefeet Of Water Per Annum To Customer WaterSupplyAgreementNumberOfAcrefeetOfWaterPerAnnumToCustomer	9500	pure
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	433000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	146000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	900000	USD
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1533000
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3442000
CY2022Q1	us-gaap	Depreciation Depreciation	121000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	103000	USD
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50750304
CY2013Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	400000
CY2013Q1	cdzi	Percentage Of Projects Annual Capacity PercentageOfProjectsAnnualCapacity	0.51	pure
	us-gaap	Payments Of Dividends PaymentsOfDividends	2737000	USD

Files In Submission

Name	View Source	Status
0001437749-22-012159-index-headers.html	Edgar Link	pending
0001437749-22-012159-index.html	Edgar Link	pending
0001437749-22-012159.txt	Edgar Link	pending
0001437749-22-012159-xbrl.zip	Edgar Link	pending
cdzi-20220331.xsd	Edgar Link	pending
cdzi-20220331_cal.xml	Edgar Link	unprocessable
cdzi-20220331_def.xml	Edgar Link	unprocessable
cdzi-20220331_lab.xml	Edgar Link	unprocessable
cdzi-20220331_pre.xml	Edgar Link	unprocessable
cdzi20220331_10q.htm	Edgar Link	pending
cdzi20220331_10q_htm.xml	Edgar Link	completed
ex_373194.htm	Edgar Link	pending
ex_373195.htm	Edgar Link	pending
ex_373196.htm	Edgar Link	pending
ex_373197.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDZI
CADIZ INC Stock $cdzi

2022 Q1 Form 10-Q Financial Statement

#000143774922012159 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDZI CADIZ INC Stock $cdzi

2022 Q1 Form 10-Q Financial Statement

#000143774922012159 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDZI
CADIZ INC Stock $cdzi